These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22928274)

  • 1. Statin-induced rhabdomyolysis and dermatomyositis: a rare combination.
    Cannon CS
    JAAPA; 2012 Aug; 25(8):30, 32-3. PubMed ID: 22928274
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
    Golomb B; Evans M
    Drug Saf; 2006; 29(12):1191; author reply 1191-2. PubMed ID: 17147465
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rhabdomyolysis associated to combined ezetimibe-statin treatment].
    Piedra León M; García Unzueta MT; Otero Martínez M; Amado Señaris JA
    Rev Clin Esp; 2007 Sep; 207(8):425-6. PubMed ID: 17688879
    [No Abstract]   [Full Text] [Related]  

  • 4. Statin-associated acute interstitial nephritis and rhabdomyolysis.
    Panchangam V
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):659-60. PubMed ID: 24821172
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rhabdomyolysis after treatment with atorvastatin detected by bone scintigraphy].
    Rubí S; Duch J; Ortín J; Setoain X; Pons F
    Rev Esp Med Nucl; 2006; 25(6):393. PubMed ID: 17173790
    [No Abstract]   [Full Text] [Related]  

  • 6. Rhabdomyolysis with atorvastatin and fusidic acid.
    O'Mahony C; Campbell VL; Al-Khayatt MS; Brull DJ
    Postgrad Med J; 2008 Jun; 84(992):325-7. PubMed ID: 18644925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine.
    Castro JG; Gutierrez L
    Am J Med; 2002 Apr; 112(6):505. PubMed ID: 11959068
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter by Rosenberg and Uretsky regarding article, "Risks associated with statin therapy: a systematic overview of randomized clinical trials".
    Rosenberg L; Uretsky S
    Circulation; 2007 Jul; 116(1):e8; author reply e9. PubMed ID: 17606852
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute rhabdomyolysis after atorvastatin and fusidic acid therapy.
    Wenisch C; Krause R; Fladerer P; El Menjawi I; Pohanka E
    Am J Med; 2000 Jul; 109(1):78. PubMed ID: 10991749
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
    Ronaldson KJ; O'Shea JM; Boyd IW
    Drug Saf; 2006; 29(11):1061-7. PubMed ID: 17061911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic rhabdomyolysis during statin therapy].
    Vergely N; Leca V; Antoine JC; Germain N; Khalfallah Y; Estour B
    Rev Med Interne; 2009 Aug; 30(8):711-3. PubMed ID: 19419805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypernatremia due to rhabdomyolysis in a patient on statin.
    Victor SM; Gnanaraj A; Abraham G; Sankardas MA
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):1037-8. PubMed ID: 21912045
    [No Abstract]   [Full Text] [Related]  

  • 13. Atorvastatin metabolite measurements as a diagnostic tool for statin-induced myopathy.
    Skottheim IB; Bogsrud MP; Hermann M; Retterstøl K; Åsberg A
    Mol Diagn Ther; 2011 Aug; 15(4):221-7. PubMed ID: 21815705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive lipid lowering with atorvastatin in coronary disease.
    Ravnskov U; Rosch PJ; Sutter MC
    N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16003834
    [No Abstract]   [Full Text] [Related]  

  • 15. Problems in dealing with very rare adverse effects of new anticancer drugs: the example of trabectedin.
    Grosso F; D'Incalci M
    Tumori; 2011; 97(2):256. PubMed ID: 21617728
    [No Abstract]   [Full Text] [Related]  

  • 16. Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine.
    Maltz HC; Balog DL; Cheigh JS
    Ann Pharmacother; 1999 Nov; 33(11):1176-9. PubMed ID: 10573315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin-associated rhabdomyolysis: is there a dose-response relationship?
    Holbrook A; Wright M; Sung M; Ribic C; Baker S
    Can J Cardiol; 2011; 27(2):146-51. PubMed ID: 21459261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin.
    Magee CN; Medani SA; Leavey SF; Conlon PJ; Clarkson MR
    Am J Kidney Dis; 2010 Nov; 56(5):e11-5. PubMed ID: 20888103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhabdomyolysis with concurrent atorvastatin and diltiazem.
    Lewin JJ; Nappi JM; Taylor MH
    Ann Pharmacother; 2002 Oct; 36(10):1546-9. PubMed ID: 12243603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV.
    Mah Ming JB; Gill MJ
    AIDS Patient Care STDS; 2003 May; 17(5):207-10. PubMed ID: 12816614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.